Alumis Earnings
NASDAQ: ALMSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
7.16+0.19 (+2.73%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Alumis earnings summary
In its most recent report on Aug 13, 2026 (Q2 2026), ALMS posted EPS of $-1.11. Revenue for the quarter was $1.7 million. Quarterly EPS is down 244.2% from the same quarter a year earlier.
Across the last 9 reports, ALMS shares moved an average of 12.7% (in either direction) in the first trading session after results, rising 4 times and falling 5 times.
Summary generated from market data by MetaCap's automated system. Methodology
ALMS earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 13, 2026 | — | $-1.11 | — | -4.5% |
| May 14, 2026 | — | $-0.74 | — | -3.7% |
| Mar 19, 2026 | — | $-0.75 | — | -1.0% |
| Nov 13, 2025 | — | $-1.06 | — | +32.2% |
| Aug 13, 2025 | — | $0.77 | — | +1.9% |
| May 14, 2025 | — | $-1.82 | — | -13.3% |
| Mar 19, 2025 | — | $35.48 | — | +50.4% |
| Nov 13, 2024 | — | $-1.73 | — | +6.9% |
| Aug 13, 2024 | — | $-23.10 | — | -0.3% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.